Frontlight ResearchEarly access
Trial site
Siloah St Trudpert Klinikum
- 9running trials
- 1closed trial
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease6 trials
- Ulcerative colitis4 trials
- Coeliac disease1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Abivax S.A.3 trials
- Merck Sharp & Dohme LLC2 trials
- AbbVie1 trial
- Dr. Falk Pharma GmbH1 trial
- Eli Lilly and Company1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease3 recruiting
- Ulcerative colitis2 recruiting
- Coeliac disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026